1. Report Introduction 2. Chronic Lymphocytic Leukemia (CLL) Epidemiology Overview at a Glance 2.1. Patient Share Distribution of Chronic Lymphocytic Leukemia (CLL) in 2017 2.2. Patient Share Distribution of Chronic Lymphocytic Leukemia (CLL) in 2027 3. Disease Background and Overview: Chronic Lymphocytic Leukemia (CLL) 3.1. Introduction 3.2. Symptoms 3.3. Etiology 3.4. Risk Factors 3.5. Pathophysiology 3.6. Diagnosis 3.7. Treatment 4. Epidemiology and Patient Population 4.1. Key Findings 4.2. Total Prevalent/ Incident Patient Population of Chronic Lymphocytic Leukemia (CLL) in 7MM 4.3. Total Prevalent/ Incident Patient Population of Chronic Lymphocytic Leukemia (CLL) in 7MM – By Countries 5. Epidemiology of Chronic Lymphocytic Leukemia (CLL) by Countries 5.1. United States 5.1.1. Assumptions and Rationale 5.1.2. Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) 5.1.3. Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) * 5.1.4. Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL)* 5.1.5. Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) 5.2. EU5 5.3. Assumptions and Rationale 5.4. Germany 5.4.1. Assumptions and Rationale 5.4.2. Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) 5.4.3. Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL)* 5.4.4. Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL)* 5.4.5. Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) 5.5. France 5.5.1. Assumptions and Rationale 5.5.2. Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) 5.5.3. Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL)* 5.5.4. Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL)* 5.5.5. Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) 5.6. Italy 5.6.1. Assumptions and Rationale 5.6.2. Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) 5.6.3. Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL)* 5.6.4. Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL)* 5.6.5. Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) 5.7. Spain 5.7.1. Assumptions and Rationale 5.7.2. Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) 5.7.3. Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL)* 5.7.4. Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL)* 5.7.5. Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) 5.8. United Kingdom 5.8.1. Assumptions and Rationale 5.8.2. Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) 5.8.3. Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL)* 5.8.4. Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL)* 5.8.5. Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) 5.9. Japan 5.9.1. Assumptions and Rationale 5.9.2. Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) 5.9.3. Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL)* 5.9.4. Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL)* 5.9.5. Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) 6. Unmet Needs of the Chronic Lymphocytic Leukemia (CLL) 7. Appendix 8. Report Methodology 8.1. Sources 9. DelveInsight Capabilities 10. Disclaimer 11. About DelveInsight *Indication Specific

Table 1: Total Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in 7MM Table 2: Total Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in 7MM by Countries Table 3: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027) Table 4: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027)* Table 5: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027)* Table 6: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027) Table 7: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) Table 8: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) * Table 9: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) * Table 10: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) Table 11: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) Table 12: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) * Table 13: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) * Table 14: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) Table 15: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) Table 16: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) * Table 17: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) * Table 18: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) Table 19: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) Table 20: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) * Table 21: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) * Table 22: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) Table 23: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) Table 24: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) * Table 25: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) * Table 26: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) Table 27: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027) Table 28: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027) * Table 29: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027) * Table 30: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027) Table 1: Total Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in 7MM Table 2: Total Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in 7MM by Countries Table 3: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027) Table 4: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027)* Table 5: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027)* Table 6: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in United States (2016-2027) Table 7: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) Table 8: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) * Table 9: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) * Table 10: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Germany (2016-2027) Table 11: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) Table 12: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) * Table 13: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) * Table 14: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in France (2016-2027) Table 15: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) Table 16: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) * Table 17: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) * Table 18: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Italy (2016-2027) Table 19: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) Table 20: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) * Table 21: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) * Table 22: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Spain (2016-2027) Table 23: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) Table 24: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) * Table 25: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) * Table 26: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in UK (2016-2027) Table 27: Prevalent/Incident Cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027) Table 28: Sub-Type Specific cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027) * Table 29: Sex- Specific Cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027) * Table 30: Diagnosed Cases of the Chronic Lymphocytic Leukemia (CLL) in Japan (2016-2027)